Gold Health Tech Gold Health Tech
search
Available for inquiry Specification-led inquiry

Medical equipment sourcing

Hemodialysis Catheter

Reference: 657915 Intensive Care
ApplicationHemodialysis
Area Of The BodyArterial, Central Venous

Associated tags

manage_search

Product fit review

Compare the available product information with your application and purchasing requirements.

description

Documentation request

Ask which specifications, manuals, or commercial documents are available for review.

support_agent

Supplier coordination

Discuss quantity, destination, packaging, and timing before confirming suitability.

Product information

Product summary

The BioFlo DuraMax chronic dialysis catheter is equipped with Endexo* Technology, a catheter material that is in-vitro more resistant to thrombus accumulation than conventional non-coated dialysis catheters that were tested (based on platelet count).One The BioFlo DuraMax dialysis catheter also offers high flow rates and optimal ease of insertion at modest arterial pressure.input:
output:The catheter exhibits a minimal amount of visible thrombus, fibrin sheath, or clot.input:
output:Endexo Technology

Endexo Technology is a permanent, non-eluting polymer that is "blended" into the polyurethane from which the catheter is fabricated. The polymer is present on all surfaces of the catheter, including the extraluminal and intraluminal surfaces, and it will remain present for the duration of the catheter's lifespan.input:
output:
The BioFlo DuraMax dialysis catheter exhibited the same thromboresistance characteristics as the Palindrome H hemodialysis catheter during a 31-day indwelling period in a sheep study.input:
output:Additional Alternatives for Enhancing Patient CareVascPak kit configurations for vascular access centers

The SafeSheath D-Pro* double valve and EmboSafe single valve peel-away sheaths offer hemostatic access with safety and security, while simultaneously reducing the risk of air embolism.input:
output:Acute in-vitro testing supports the reduction in thrombus accumulation (based on platelet count). Clinical performance in terms of thrombus formation is not necessarily predicted by pre-clinical in-vitro evaluations.

According to benchtop testing conducted for up to two hours using bovine blood, the results may not be indicative of clinical outcomes.

Information stored in a database

Continue your equipment review

Related products